ストックスクリーナーアプリを入手
193.95
2.21%
4.19
アフターアワーズ：
193.95
Revolution Medicines Inc (RVMD) 最新ニュース
About 3% of U.S. patients with metastatic pancreatic cancer survive five years. A drug pair starts testing in patients. - Stock Titan
Revolution Medicines (NasdaqGS:RVMD) Stock Forecast & Analyst Predictions - Simply Wall Street
Revolution Medicines’ CDO Sandler sells $1.2m in stock - Investing.com
Form 4 Revolution Medicines Inc For: 1 October By Investing.com - Investing.com UK
Revolution Medicines SVP Cislini sells $158,599 in shares By Investing.com - Investing.com Nigeria
Form 4 Revolution Medicines Inc For: 29 September By Investing.com - Investing.com South Africa
Revolution Medicines SVP Cislini sells $158,599 in shares - Investing.com
Form 4 Revolution Medicines Inc For: 29 September By Investing.com - Investing.com UK
Revolution Medicines SVP Jeff Cislini Sells 765 Shares Under 10b5-1 Trading Plan - Kalkine Media
Revolution Medicines (RVMD) counsel Jeff Cislini sold 765 shares at $207.3201 each under a trading plan. - Stock Titan
6,000 shares from exercised options are listed for an officer’s proposed sale at Revolution Medicines (RVMD). - Stock Titan
Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com South Africa
Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com Nigeria
Revolution Medicines officer Mancini sells $743k in stock - Investing.com
Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com UK
Stock options are the source of 9,363 shares a Revolution Medicines (RVMD) officer proposes to sell. - Stock Titan
Revolution Medicines director Elizabeth Anderson sells $1.96m in stock - Investing.com
Revolution Medicines (RVMD) director exercises options for 5,070 shares and sells 10,143 shares. - Stock Titan
After three earlier sales, an officer proposes selling 587 more Revolution Medicines (RVMD) shares. - Stock Titan
Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes - Yahoo Finance
Form 4 Revolution Medicines Inc For: 22 September By Investing.com - Investing.com Canada
Revolution Medicines (NASDAQ: RVMD) director plans stock sale from option exercise - Stock Titan
Revolution Medicines chief development officer sells $67,940 in stock - Investing.com
Revolution Medicines officer sells $353,449 in shares - Investing.com
Revolution Medicines COO Margaret Horn sells $989,612 of common stock - Investing.com
Revolution Medicines’ senior advisor sells $1.1m in stock - Investing.com
Revolution Medicines CEO Mark Goldsmith sells $2.78m in stock - Investing.com
Revolution Medicines’ Jeff Cislini sells $670k in common stock - Investing.com
Revolution Medicines CFO Jack Anders sells $807,513 in stock - Investing.com
Revolution Medicines (RVMD) exec sells 1,774 shares, keeps 39,575 RSUs - Stock Titan
Revolution Medicines (RVMD) legal chief makes pre-set stock sale for taxes - Stock Titan
Revolution Medicines (RVMD) insider adds new sale after multimillion-dollar trades - Stock Titan
Revolution Medicines (RVMD) CFO sells shares under tax-driven plan - Stock Titan
Officer at Revolution Medicines (RVMD) plans 331-share sale - Stock Titan
Revolution Medicines officer plans $484K sale | RVMD SEC FilingForm 144 - Stock Titan
Officer at Revolution Medicines (NASDAQ: RVMD) plans 4,830-share stock sale after RSU vesting - Stock Titan
Over $16M in recent stock sales as Revolution Medicines (NASDAQ: RVMD) filer Mark A. Goldsmith plans another trade - Stock Titan
Revolution Medicines (RVMD) exec exercises options, sells stock - Stock Titan
(RVMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Revolution Medicines director Lorence Kim sells $3.58m in stock By Investing.com - Investing.com South Africa
Revolution Medicines (RVMD) Gets its First Approved Drug, and the Market Shrugs - Yahoo Finance
Abu Dhabi Investment Council Co P.J.S.C's Revolution Medicines Inc(RVMD) Holding History - GuruFocus
Revolution Medicines (NASDAQ: RVMD) officer plans multi-million stock option share sale - Stock Titan
Verastem CSO Pachter: The First RAS Drug Is a Floor, Not a Ceiling - finance.biggo.com
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Revolution Medicines director Lorence Kim sells $3.58m in stock By Investing.com - Investing.com Australia
Revolution Medicines director Lorence Kim sells $3.58m in stock By Investing.com - Investing.com Canada
Revolution Medicines director Lorence Kim sells $3.58m in stock - investing.com
Revolution Medicines Director Lorence H. Kim Sells 14,090 Shares via Revocable Trust Under 10b5-1 Plan - Kalkine Media
Planned multimillion stock sale at Revolution Medicines (RVMD) - Stock Titan
1.15%
1.49%
大文字化:
|
ボリューム (24 時間):